The Oncology Drugs Industry, valued at USD 198.73 billion in 2022, is poised for substantial growth over the coming years. It is expected to reach USD 471.35 billion by 2030, expanding at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030. This rapid expansion is driven by increasing cancer prevalence, advancements in drug development, and rising investment in oncology...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)